PTC Inc. stock is a Buy as Creo & Windchill drive R&D lock-in, 27% RPO growth, and 95% recurring revenue, plus $365M buybacks. Click here to read more on PTC.

General-purpose models struggle with messy, industry-specific data. A three-layer AI stack from Trunk Tools cut document review cycles from 60 days to 10.

With data from nearly 750,000 participants, the NIH initiative is now the largest integrated genomic and electronic health record database in the world, research officials say.